SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression

Expression profiling and biomarker(s) discovery aim to provide means for tumour diagnosis, classification, therapy response and prognosis. The identification of novel markers could potentially lead to the building of robust early detection strategies and personalized, effective breast cancer therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeidan, Bashar A, Townsend, Paul A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481502/
https://www.ncbi.nlm.nih.gov/pubmed/18644101
http://dx.doi.org/10.1186/bcr2107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481502/
https://www.ncbi.nlm.nih.gov/pubmed/18644101
http://dx.doi.org/10.1186/bcr2107

Ejemplares similares